A new model (Alfalfa-Warfarin-GIB) for predicting the risk of major gastrointestinal bleeding in warfarin patients
暂无分享,去创建一个
Guan-hua Fang | Jin-hua Zhang | M. Lv | Shuyi Wu | Fuxin Ma | Fei Zhang
[1] Nianxu Huang,et al. A new model to predict the risk of major gastrointestinal bleeding in patients on direct oral anticoagulants (dabigatran and rivaroxaban) , 2022, British journal of clinical pharmacology.
[2] A. Santamaría,et al. Severity of gastrointestinal bleeding is similar between patients receiving direct oral anticoagulants or vitamin K antagonists. , 2022, Revista Espanola de Enfermedades Digestivas.
[3] A. Zullo,et al. Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO). , 2020, European journal of internal medicine.
[4] B. Holtz. Patients Perceptions of Telemedicine Visits Before and After the Coronavirus Disease 2019 Pandemic. , 2020, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.
[5] Le Zhang,et al. Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants-a Systematic Review and Meta-analysis. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[6] L. Køber,et al. Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study. , 2019, European heart journal. Cardiovascular pharmacotherapy.
[7] A. Kfoury,et al. Novel Model to Predict Gastrointestinal Bleeding During Left Ventricular Assist Device Support: The Utah Bleeding Risk Score , 2018, Circulation. Heart failure.
[8] J. Akiyama,et al. New predictive model for acute gastrointestinal bleeding in patients taking oral anticoagulants: A cohort study , 2018, Journal of gastroenterology and hepatology.
[9] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[10] Á. Lanas,et al. Risk of gastrointestinal bleeding during anticoagulant treatment , 2017, Expert opinion on drug safety.
[11] L. Strate,et al. ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding , 2016, The American Journal of Gastroenterology.
[12] E. Tremoli,et al. Gastrointestinal bleeding in patients receiving oral anticoagulation: Current treatment and pharmacological perspectives. , 2015, Thrombosis research.
[13] P. Hsu,et al. Gastrointestinal Hemorrhage in Warfarin Anticoagulated Patients: Incidence, Risk Factor, Management, and Outcome , 2014, BioMed research international.
[14] L. Gerson. Causes of gastrointestinal hemorrhage in patients with chronic renal failure. , 2013, Gastroenterology.
[15] P. T. Onundarson,et al. Screening for anemia in patients on warfarin facilitates diagnosis of gastrointestinal malignancies and pre-malignant lesions. , 2012, Thrombosis research.
[16] D. Fisher,et al. Does this patient have a severe upper gastrointestinal bleed? , 2012, JAMA.
[17] Loren Laine,et al. Management of Patients With Ulcer Bleeding , 2012, The American Journal of Gastroenterology.
[18] D. Singer,et al. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. , 2011, Journal of the American College of Cardiology.
[19] Gregory Y H Lip,et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.
[20] J. Mandrekar. Receiver operating characteristic curve in diagnostic test assessment. , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[21] L. Jacobs. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly. , 2008, Cardiology clinics.
[22] M. Rich,et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). , 2006, American heart journal.
[23] S. Schulman,et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients , 2005, Journal of thrombosis and haemostasis : JTH.
[24] M. Pirmohamed,et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.
[25] D. Nelson,et al. Acute GI bleeding in the setting of supratherapeutic international normalized ratio in patients taking warfarin: endoscopic diagnosis, clinical management, and outcomes. , 2003, Gastrointestinal endoscopy.
[26] Valentin Fuster,et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. , 2003, Circulation.
[27] F. Fulfaro,et al. Gastrointestinal bleeding in advanced cancer patients. , 2000, Journal of pain and symptom management.
[28] A. Graham,et al. Gastrointestinal Bleeding. , 2016, Emergency medicine clinics of North America.
[29] L. Strate,et al. ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding , 2016, The American Journal of Gastroenterology.
[30] J. Lei,et al. Risk of upper gastrointestinal bleeding from different drug combinations. , 2014, Gastroenterology.